{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:09:05Z","timestamp":1780376945724,"version":"3.54.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91213302"],"award-info":[{"award-number":["91213302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21402076"],"award-info":[{"award-number":["21402076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91413107"],"award-info":[{"award-number":["91413107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473095"],"award-info":[{"award-number":["81473095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Science and Technology","award":["2012ZX09504001-003"],"award-info":[{"award-number":["2012ZX09504001-003"]}]},{"name":"Program for Changjiang Scholars","award":["PCSIRT"],"award-info":[{"award-number":["PCSIRT"]}]},{"name":"Innovative Research Team in University","award":["IRT1137"],"award-info":[{"award-number":["IRT1137"]}]},{"name":"Fundamental Research Funds","award":["lzujbky-2015-164"],"award-info":[{"award-number":["lzujbky-2015-164"]}]},{"name":"Fundamental Research Funds","award":["lzujbky-2015-168"],"award-info":[{"award-number":["lzujbky-2015-168"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.neuropharm.2015.06.010","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T17:40:41Z","timestamp":1435167641000},"page":"312-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Endomorphin-1 analogues (MELs) penetrate the blood\u2013brain barrier and exhibit good analgesic effects with minimal side effects"],"prefix":"10.1016","volume":"97","author":[{"given":"Yuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.06.010_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5055\/jom.2010.0063","article-title":"Oxycodone-related side effects: impact on degree of bother, adherence, pain relief, satisfaction, and quality of life","volume":"7","author":"Anastassopoulos","year":"2011","journal-title":"J.\u00a0Opioid Manag."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF02605761","article-title":"Segmental colonic transit time","volume":"24","author":"Arhan","year":"1981","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/egh.12.63","article-title":"Methylnaltrexone for the treatment of opioid-induced constipation","volume":"7","author":"Bader","year":"2013","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(97)00227-3","article-title":"Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract","volume":"81","author":"Bagnol","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib5","article-title":"Models of nociception: hot-plate, tail-flick, and formalin tests in rodents","volume":"8","author":"Bannon","year":"2007","journal-title":"Curr. Protoc. Neurosci. Chapter"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib6","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/jn\/109.9.1592","article-title":"Sites of organic acid production and patterns of digesta movement in the gastrointestinal tract of dogs","volume":"109","author":"Banta","year":"1979","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib7","first-page":"1","article-title":"Models of neuropathic pain in rat","volume":"14","author":"Bennett","year":"2003","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib8","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ajg.2011.30","article-title":"Opioid-induced constipation: challenges and therapeutic opportunities","volume":"106","author":"Camilleri","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1196\/annals.1414.033","article-title":"Cancer pain and analgesia","volume":"1138","author":"Christo","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/bja\/81.1.58","article-title":"Opioid tolerance: the clinical perspective","volume":"81","author":"Collett","year":"1998","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-3940(97)13344-4","article-title":"Modulation of neurotransmitter release by opioid mu- and kappa-receptors from adrenergic terminals in the myenteric plexus of the guinea-pig colon: effect of alpha 2-autoreceptor blockade","volume":"222","author":"Cosentino","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib13","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1164\/ajrccm.162.3.9911102","article-title":"Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine","volume":"162","author":"Czapla","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1124\/pr.59.1.3","article-title":"The endomorphin system and its evolving neurophysiological role","volume":"59","author":"Fichna","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(96)00266-5","article-title":"Opioid receptor expression in the rat gastrointestinal tract: a quantitative study with comparison to the brain","volume":"46","author":"Fickel","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1476-5381.1985.tb11085.x","article-title":"Contractor responses of the isolated colon of the mouse to morphine and some opioid peptides","volume":"85","author":"Fontaine","year":"1985","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib17","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/ajg.2013.169","article-title":"Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis","volume":"108","author":"Ford","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1568026043451663","article-title":"New trends in the development of opioid peptide analogues as advanced remedies for pain relief","volume":"4","author":"Gentilucci","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1476-5381.1980.tb14551.x","article-title":"Acute effects of morphine and opioid peptides on the motility and responses of rat colon to electrical stimulation","volume":"68","author":"Gillan","year":"1980","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1756-6606-5-4","article-title":"In\u00a0vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist-neurokinin 1 receptor antagonist chimera","volume":"5","author":"Guillemyn","year":"2012","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuropharm.2013.04.020","article-title":"In\u00a0vitro binding affinities of a series of flavonoids for mu-opioid receptors. Antinociceptive effect of the synthetic flavonoid 3,3-dibromoflavanone in mice","volume":"72","author":"Higgs","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/258577a0","article-title":"Identification of two related pentapeptides from the brain with potent opiate agonist activity","volume":"258","author":"Hughes","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib23","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2174\/138161210790963869","article-title":"Development of opioid peptide analogs for pain relief","volume":"16","author":"Janecka","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib24","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.peptides.2008.07.015","article-title":"Enzymatic degradation of endomorphins","volume":"29","author":"Janecka","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1440-1681.1995.tb02029.x","article-title":"Opioids and pain","volume":"22","author":"Kanjhan","year":"1995","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib26","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.2174\/138161210793563491","article-title":"Concepts for biologically active peptides","volume":"16","author":"Kastin","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib27","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/bph.12222","article-title":"Efficacy and ligand bias at the mu-opioid receptor","volume":"169","author":"Kelly","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib28","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/cmdc.201000077","article-title":"Recent advances in endomorphin engineering","volume":"5","author":"Keresztes","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0301-0082(02)00008-4","article-title":"Exploring the opioid system by gene knockout","volume":"66","author":"Kieffer","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003495-200363070-00003","article-title":"Opioid-induced bowel dysfunction: pathophysiology and potential new therapies","volume":"63","author":"Kurz","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","article-title":"Animal models of nociception","volume":"53","author":"Le Bars","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/med.20222","article-title":"Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs","volume":"32","author":"Liu","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib33","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1021\/jm400195y","article-title":"Design, synthesis, and pharmacological characterization of novel endomorphin-1 analogues as extremely potent mu-opioid agonists","volume":"56","author":"Liu","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2147\/TCRM.S3147","article-title":"Management of postoperative ileus: focus on alvimopan","volume":"4","author":"Marderstein","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuropharm.2008.05.003","volume":"55","author":"Matsumoto","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(99)00089-0","article-title":"Dipeptidyl-peptidase IV (CD26)\u2013role in the inactivation of regulatory peptides","volume":"85","author":"Mentlein","year":"1999","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1476-5381.1980.tb10849.x","article-title":"Effects of endorphins on different parts of the gastrointestinal tract of rat and guinea-pig in\u00a0vitro","volume":"68","author":"Nijkamp","year":"1980","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1254\/jjp.78.83","article-title":"Inhibitory effect of endomorphin-1 and -2 on acetylcholine release from myenteric plexus of guinea pig ileum","volume":"78","author":"Nishiwaki","year":"1998","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.pain.2008.01.027","article-title":"Prevalence and characteristics of opioid use in the US adult population","volume":"138","author":"Parsells Kelly","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib40","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1476-5381.2012.02075.x","article-title":"Ligand-directed signalling within the opioid receptor family","volume":"167","author":"Pradhan","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib41","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/0024-3205(87)90520-0","article-title":"Colonic bead expulsion time in normal and mu-opioid receptor deficient (CXBK) mice following central (ICV) administration of mu- and delta-opioid agonists","volume":"41","author":"Raffa","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1476-5381.1984.tb10130.x","article-title":"The role of accelerated colonic transit in prostaglandin-induced diarrhoea and its inhibition by prostacyclin","volume":"83","author":"Rush","year":"1984","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.5055\/jom.2010.0036","article-title":"Defining clinical issues around tolerance, hyperalgesia, and addiction: a quantitative and qualitative outcome study of long-term opioid dosing in a chronic pain practice","volume":"6","author":"Schneider","year":"2010","journal-title":"J.\u00a0Opioid Manag."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0006-8993(98)01121-4","article-title":"Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV","volume":"815","author":"Shane","year":"1999","journal-title":"Brain Res."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.neuropharm.2015.06.010_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1743-3150.2004.00553.x","article-title":"The opioid system in the gastrointestinal tract","volume":"16","author":"Sternini","year":"2004","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib46","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2982.2010.01478.x","article-title":"Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice","volume":"22","author":"Storr","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pain.2007.03.008","article-title":"Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain","volume":"133","author":"Suardiaz","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib48","first-page":"1347","article-title":"Management of common opioid-induced adverse effects","volume":"74","author":"Swegle","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib49","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0196-9781(02)00100-6","article-title":"In\u00a0vitro quantitative study of the degradation of endomorphins","volume":"23","author":"Tomboly","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib50","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/PL00005313","article-title":"Endomorphin-1 and endomorphin-2 activate mu-opioid receptors in myenteric neurons of the guinea-pig small intestine","volume":"358","author":"Tonini","year":"1998","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib51","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2174\/138161211797440203","article-title":"Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology","volume":"17","author":"Tournier","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuropharm.2013.06.011","article-title":"A\u00a0novel, potent, oral active and safe antinociceptive pyrazole targeting kappa opioid receptors","volume":"73","author":"Trevisan","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib53","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.2174\/0929867311320220002","article-title":"Endomorphin derivatives with improved pharmacological properties","volume":"20","author":"Varamini","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib54","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.bmc.2013.01.044","article-title":"Peripherally acting novel lipo-endomorphin-1 peptides in neuropathic pain without producing constipation","volume":"21","author":"Varamini","year":"2013","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib55","doi-asserted-by":"crossref","first-page":"e41909","DOI":"10.1371\/journal.pone.0041909","article-title":"Lipo-endomorphin-1 derivatives with systemic activity against neuropathic pain without producing constipation","volume":"7","author":"Varamini","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib56","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1021\/jm300418d","article-title":"Synthesis and biological evaluation of an orally active glycosylated endomorphin-1","volume":"55","author":"Varamini","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib57","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1476-5381.2012.02068.x","article-title":"Modulation of gastrointestinal function by MuDelta, a mixed micro opioid receptor agonist\/micro opioid receptor antagonist","volume":"167","author":"Wade","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib58","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1021\/jm300664y","article-title":"A\u00a0new class of highly potent and selective endomorphin-1 analogues containing alpha-methylene-beta-aminopropanoic acids (map)","volume":"55","author":"Wang","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib59","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0196-9781(00)00340-5","article-title":"Dissociation of analgesic and rewarding effects of endomorphin-1 in rats","volume":"21","author":"Wilson","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2015.06.010_bib60","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.bcp.2007.01.011","article-title":"In\u00a0vitro characterization of the effects of endomorphin 1 and 2, endogenous ligands for mu-opioid receptors, on mouse colonic motility","volume":"73","author":"Yu","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.06.010_bib61","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/386499a0","article-title":"A\u00a0potent and selective endogenous agonist for the mu-opiate receptor","volume":"386","author":"Zadina","year":"1997","journal-title":"Nature"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815002683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815002683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:49:30Z","timestamp":1758437370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815002683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":61,"alternative-id":["S0028390815002683"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.06.010","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endomorphin-1 analogues (MELs) penetrate the blood\u2013brain barrier and exhibit good analgesic effects with minimal side effects","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}